Jacobs Levy Equity Management’s Biote Corp BTMD Stock Holding History

Jacobs Levy Equity Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Buy	151,049 +52,444	+53%	+$105K	﹤0.01%	917
2025 Q4	$256K	Sell	98,605 -44,125	-31%	-$121K	﹤0.01%	871
2025 Q3	$428K	Sell	142,730 -79,826	-36%	-$285K	﹤0.01%	838
2025 Q2	$895K	Sell	222,556 -13,351	-6%	-$49.3K	﹤0.01%	777
2025 Q1	$786K	Sell	235,907 -34,568	-13%	-$165K	﹤0.01%	855
2024 Q4	$1.67M	Sell	270,475 -1,902	-0.7%	-$11.1K	0.01%	631
2024 Q3	$1.52M	Buy	272,377 +54,302	+25%	+$362K	0.01%	655
2024 Q2	$1.63M	Buy	+218,075	New	+$1.35M	0.01%	642

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobs Levy Equity Management's BTMD Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Biote Corp (BTMD) stake by 53% in Q1 2026, buying an estimated $105K and bringing the position to 151,049 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Jacobs Levy Equity Management first reported a position in BTMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.67M in Q4 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

Jacobs Levy Equity Management held 151,049 shares of Biote Corp worth $204K as of Q1 2026.
Jacobs Levy Equity Management bought 52,444 Biote Corp shares in Q1 2026, an estimated $105K.
Biote Corp made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #917 holding.
Jacobs Levy Equity Management first reported a position in Biote Corp in Q2 2024 and has held it in 8 quarters since.
Jacobs Levy Equity Management's Biote Corp position peaked at $1.67M in Q4 2024.
84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.